(Q40690467)

22 September 2017

title

Cisplatin sensitivity in Hmbg1-/- and Hmbg1+/+ mouse cells (English)

1 reference

22 September 2017

1 reference

Min Wei

1

1 reference

22 September 2017

Olga Burenkova

series ordinal

2

1 reference

22 September 2017

Stephen J Lippard

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

11 November 2002

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

1769-1773

1 reference

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Recognition of cisplatin adducts by cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

The HMG-1 box protein family: classification and functional relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

High mobility group protein-1 (HMG-1) is a unique activator of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

An enzyme-release assay for natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Heterogeneity of high-mobility-group protein 2. Enrichment of a rapidly migrating form in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Testicular germ-cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Cellular and molecular determinants of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

Evidence for a beta2-adrenergic/arachidonic acid pathway in ventricular cardiomyocytes. Regulation by the beta1-adrenergic/camp pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

HMG domain proteins induce sharp bends in cisplatin-modified DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210562200

21 January 2018

Identifiers

DOI

10.1074/JBC.M210562200

1 reference

22 September 2017

1 reference